(Q39550104)

13 September 2017

What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4? (English)

1 reference

13 September 2017

H Forsman

1

1 reference

13 September 2017

K Onnheim

series ordinal

2

1 reference

13 September 2017

E Andreasson

series ordinal

3

1 reference

13 September 2017

C Dahlgren

series ordinal

4

1 reference

13 September 2017

1 September 2011

1 reference

Scandinavian Journal of Immunology

13 September 2017

1 reference

13 September 2017

74

1 reference

13 September 2017

227-234

1 reference

13 September 2017

3

1 reference

Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists

13 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Resolution of inflammation: state of the art, definitions and terms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Ligand recognition and activation of formyl peptide receptors in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Inhibition of chemoattractant N-formyl peptide receptor trafficking by active arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Novel roles for arrestins in the post-endocytic trafficking of G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

The pyrazolone originally reported to be a formyl peptide receptor (FPR) 2/ALX-selective agonist is instead an FPR1 and FPR2/ALX dual agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Formyl peptide receptor 1 and 2 dual agonist inhibits human neutrophil chemotaxis by the induction of chemoattractant receptor cross-desensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Changes in activation states of murine polymorphonuclear leukocytes (PMN) during inflammation: a comparison of bone marrow and peritoneal exudate PMN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Respiratory burst in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

The FPR2-induced rise in cytosolic calcium in human neutrophils relies on an emptying of intracellular calcium stores and is inhibited by a gelsolin-derived PIP2-binding peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Circulating mitochondrial DAMPs cause inflammatory responses to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Discovery of selective probes and antagonists for G-protein-coupled receptors FPR/FPRL1 and GPR30

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02570.X

10.1111/J.1365-3083.2011.02570.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference